Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 09, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
The only material change disclosed is a specific share transaction:
- Mr J S Heslop: Transferred 7,335 Ordinary shares by gift to Mrs Heslop on June 06, 2006.
- Notification Date: The company was advised of this transaction on June 09, 2006.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transfer in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Checklist
- Verify the total shareholding of Mr J S Heslop and Mrs Heslop following the June 06, 2006 transfer.
- Confirm that the transaction was properly recorded under Disclosure Rule 3.1.4R(1)(b).
- Note that this filing does not contain financial results; refer to the company's Form 20-F or interim reports for financial metrics.